Abstract
Imatinib 40-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Issue: Nov/Dec 2016 - Volume 20, Number 6
Page(s): 510
Download in electronic PDF format for $75
Abstract
A formulation for preparing Imatinib 40-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords
- imatninib
- formulation
- hazardous medication
- antineoplastic agent
- cancer
- leukemia
- gastrointestinal stromal tumor
- GIST
- protein tyrosine kinase inhibitor
- BCR-ABL inhibitor
- receptor tyrosine kinase inhibitor
- platelet-derived growth factor receptor
- PDGF
- PDGFR
- stem cell factor inhibitor
- SCF
- c-kit inhibitor
Related Categories
- CANCER AND AIDS
- FORMULATIONS
- HAZARDOUS DRUGS